| Title |
Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
|
|---|---|
| Published in |
Biologics: Targets & Therapy, August 2013
|
| DOI | 10.2147/btt.s47438 |
| Pubmed ID | |
| Authors |
Chonlatip Pipattanaboon, Tadahiro Sasaki, Mitsuhiro Nishimura, Chayanee Setthapramote, Pannamthip Pitaksajjakul, Pornsawan Leaungwutiwong, Kriengsak Limkittikul, Orapim Puiprom, Mikiko Sasayama, Panjaporn Chaichana, Tamaki Okabayashi, Takeshi Kurosu, Ken-ichiro Ono, Pongrama Ramasoota, Kazuyoshi Ikuta |
| Abstract |
Hybridomas that produce human monoclonal antibodies (HuMAbs) against Dengue virus (DV) had been prepared previously using peripheral blood lymphocytes from patients with DV during the acute and convalescent phases of a secondary infection. Anti-DV envelope glycoprotein (E) 99 clones, anti-DV premembrane protein (prM) 8 clones, and anti-DV nonstructural protein 1 (NS1) 4 clones were derived from four acute-phase patients, and anti-DV E 2 clones, anti-DV prM 2 clones, and anti-DV NS1 8 clones were derived from five convalescent-phase patients. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 3% |
| Unknown | 31 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 22% |
| Student > Ph. D. Student | 6 | 19% |
| Unspecified | 3 | 9% |
| Student > Master | 3 | 9% |
| Student > Doctoral Student | 2 | 6% |
| Other | 8 | 25% |
| Unknown | 3 | 9% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 10 | 31% |
| Medicine and Dentistry | 6 | 19% |
| Unspecified | 3 | 9% |
| Agricultural and Biological Sciences | 3 | 9% |
| Environmental Science | 1 | 3% |
| Other | 3 | 9% |
| Unknown | 6 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2016.
All research outputs
#7,960,512
of 25,374,917 outputs
Outputs from Biologics: Targets & Therapy
#101
of 284 outputs
Outputs of similar age
#64,589
of 210,078 outputs
Outputs of similar age from Biologics: Targets & Therapy
#2
of 4 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,078 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.